Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-11FDA Approved: TRAZIMERA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved TRAZIMERA (trastuzumab-qyyP) from Pfizer as an original biologics license application. It is a biosimilar to trastuzumab indica…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating NEPA to prevent chemotherapy-induced nausea and vomiting in breast cancer patients (completed).
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab and pertuzumab or bevacizumab with combination chemotherapy in stage II–III breast cancer has completed…
-
FDA approval · 2019-03-04FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) from AbbVie Inc.
-
FDA approval · 2019-03-04FDA Approved: FULVESTRANT — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's generic Fulvestrant under Original Application (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating Arimidex with or without Faslodex in postmenopausal women with HR-positive breast cancer has completed with results…
-
FDA approval · 2019-02-28FDA Approved: HERCEPTIN HYLECTA — Original Application (Genentech, Inc.)
FDA approved HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk) under an original application by Genentech for treating HER2-positive br…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel [Phase 2]
Phase 2 biomarker study in HER2-negative metastatic breast cancer treated with bevacizumab and paclitaxel has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer [Phase 1, Phase 2]
Open-label dose-finding study evaluating TRC105 in combination with capecitabine for metastatic breast cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: BREAST CANCER AND EXERCISE [Phase 3]
Phase 3 trial update investigating exercise in breast cancer patients, focusing on osteoporosis prevention, quality of life, physical fitnes…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of oral Navelbine in HER2-negative metastatic breast cancer in female patients.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer [Phase 3]
A Phase 3 trial evaluating efficacy and safety in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer h…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT) [NA]
Clinical trial assessing diagnostic accuracy of digital breast tomosynthesis vs mammography for breast cancer detection; study terminated wi…
-
FDA approval · 2019-02-22FDA Approved: EXEMESTANE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Exemestane submitted by Cipla USA Inc.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Increasing Physical Activity Among Breast Cancer Survivors With Depression [NA]
A trial evaluating increasing physical activity among breast cancer survivors with depression has completed, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients [NA]
This clinical trial update shows that the study of Somnage® for sleep and mood in cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: A Pilot Study - Comparison of Two Hologic 3D Mammography Systems
A pilot study comparing two Hologic 3D mammography systems has been completed to evaluate imaging performance for breast cancer screening.
-
CLINICAL_TRIALS research · 2019-02-22Clinical Trial Update: Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario [NA]
Clinical trial update describing efforts to incorporate exercise evidence into routine breast cancer care in Ontario to bridge research and …
-
FDA approval · 2019-02-22FDA Approved: EXEMESTANE — Supplemental Application (Upsher-Smith Laboratories, Inc.)
The FDA approved a supplemental application for Exemestane (Upsher-Smith Laboratories) under an ANDA, affecting a generic aromatase inhibito…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours [Phase 2]
A Phase 2 trial of capecitabine plus radiotherapy for locally relapsed HER2-negative breast cancer. The study status is terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: APBI: 27Gy in 5 Fractions for Early Breast Cancer [NA]
This update covers a trial of accelerated partial breast irradiation (APBI) delivering 27 Gy in 5 fractions for early breast cancer. The cur…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: A Sustainable Approach to Increasing Cancer Screening [NA]
A Harvard School of Public Health-led clinical trial on sustainable strategies to increase cancer screening has completed. The study address…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen [Phase 2]
A Phase 2 clinical trial evaluated red clover and lifestyle changes to alleviate menopausal symptoms in premenopausal breast cancer patients…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors
This clinical trial update reports on comorbidities and health care services utilization among long-term breast cancer survivors, with the s…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer [Phase 1]
A Phase I open-label study evaluating the safety and preliminary efficacy of olaparib in combination with carboplatin in advanced HER-2 nega…